BrainVectis Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

BrainVectis General Information

Description

Developer of a gene therapy intended for neuro-degenerative diseases. The company develops gene therapy treatments for Alzheimer's and Huntington's diseases by restoring cholesterol metabolism in the brain, providing medical practitioners with treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain.

Contact Information

Website
www.brainvectis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • CHU Pitié Salpêtrière
  • 75013 Paris
  • France
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Acquirer
AskBio
Vertical(s)
Life Sciences
Corporate Office
  • CHU Pitié Salpêtrière
  • 75013 Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BrainVectis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Apr-2020 Completed Generating Revenue
1. Early Stage VC (Series A) 13-Sep-2016 Completed Startup
To view BrainVectis’s complete valuation and funding history, request access »

BrainVectis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gene therapy intended for neuro-degenerative diseases. The company develops gene therapy treatments for A
Biotechnology
Paris, France
5 As of 2016

Lexington, MA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BrainVectis Competitors (2)

One of BrainVectis’s 2 competitors is Voyager Therapeutics, a Corporation company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Corporation Lexington, MA
Spark Therapeutics Formerly VC-backed Philadelphia, PA
You’re viewing 2 of 2 competitors. Get the full list »

BrainVectis Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

BrainVectis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2944358-T3 Expression vector for cholesterol 24-hydrolase in polyglutamine repetitive spinocerebellar ataxia therapy Active 30-Jan-2017
EP-3574091-A1 Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias Active 30-Jan-2017
EP-3574091-B1 Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias Active 30-Jan-2017
US-12138298-B2 Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias Active 30-Jan-2017
US-20190343927-A1 Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias Active 30-Jan-2017 A61K38/44
To view BrainVectis’s complete patent history, request access »

BrainVectis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrainVectis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Erganeo Venture Capital Minority
To view BrainVectis’s complete investors history, request access »

Ready to get started?

Request a free trial

BrainVectis FAQs

  • When was BrainVectis founded?

    BrainVectis was founded in 2015.

  • Where is BrainVectis headquartered?

    BrainVectis is headquartered in Paris, France.

  • What is the size of BrainVectis?

    BrainVectis has 5 total employees.

  • What industry is BrainVectis in?

    BrainVectis’s primary industry is Biotechnology.

  • Is BrainVectis a private or public company?

    BrainVectis is a Private company.

  • What is BrainVectis’s current revenue?

    The current revenue for BrainVectis is .

  • How much funding has BrainVectis raised over time?

    BrainVectis has raised $1.12M.

  • Who are BrainVectis’s investors?

    Erganeo has invested in BrainVectis.

  • Who are BrainVectis’s competitors?

    Voyager Therapeutics and Spark Therapeutics are competitors of BrainVectis.

  • When was BrainVectis acquired?

    BrainVectis was acquired on 22-Apr-2020.

  • Who acquired BrainVectis?

    BrainVectis was acquired by AskBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »